Testing effectiveness (Phase 2)UnknownNCT02776605What this trial is testingPonatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic LeukemiaWho this might be right forALL PETHEMA Foundation 30
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Testing effectiveness (Phase 2)Study completedNCT00171249What this trial is testingAn Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ LeukemiaWho this might be right forPhiladelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT02081378What this trial is testingA Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 326
Very early researchLooking for participantsNCT07074496What this trial is testingEfficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Who this might be right forPhiladelphia Chromosome-Positive Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Ended earlyNCT00464113What this trial is testingStudy of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaWho this might be right forChronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive Exelixis 49
Testing effectiveness (Phase 2)Study completedNCT02997761What this trial is testingIbrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaWho this might be right forAdult B Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive University of California, Davis 19
Not applicableUnknownNCT03709017What this trial is testingIclusig PMS in CML or Ph+ALL PatientsWho this might be right forChronic Myeloid LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Korea Otsuka Pharmaceutical Co., Ltd. 50
Not applicableStudy completedNCT04965649What this trial is testingIs There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.Who this might be right forLeukemiaMyelogenous LeukemiaChronic Leukemia+1 more Centre Hospitalier Universitaire de Nīmes 30
Testing effectiveness (Phase 2)Study completedNCT02888990What this trial is testingDasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Lymphoblastic, Acute Versailles Hospital 71
Early research (Phase 1)Looking for participantsNCT07040982What this trial is testingAsciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 City of Hope Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147612What this trial is testingLow-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia With BCR-ABL1+3 more M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)UnknownNCT01005758What this trial is testingCombination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Ohio State University Comprehensive Cancer Center 180
Testing effectiveness (Phase 2)UnknownNCT00199186What this trial is testingStudy Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)Who this might be right forPhiladelphia Positive Acute Lymphoblastic LeukemiaLymphoid Blastic Phase of Chronic Myeloid Leukemia Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Study completedNCT00844298What this trial is testingNilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Asan Medical Center 91
Large-scale testing (Phase 3)UnknownNCT02611492What this trial is testingA Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young AdultsWho this might be right forPhiladelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia Assistance Publique - Hôpitaux de Paris 265
Early research (Phase 1)Study completedNCT00103701What this trial is testingBMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Myeloid, Chronic-phaseLeukemia, Lymphoblastic, Acute, Philadelphia-positive Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00015860What this trial is testingSTI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic LeukemiaWho this might be right forLeukemia Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04554459What this trial is testingPonatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALLWho this might be right forAcute Lymphoblastic Leukemia, AdultPh+ ALLNewly Diagnosed Institute of Hematology and Blood Transfusion, Czech Republic 4
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72